Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
(Reuters) - Women with an especially deadly type of breast cancer who received a treatment regimen containing an experimental AbbVie Inc drug prior to surgery are likely to have a significantly better response than those who get a standard chemotherapy regimen, according to data from a clinical trial.
People 2 to 24 months post-cancer treatment may find relief from lingering sleep issues that developed during or after treatment by practicing yoga twice a week, a study published in the Journal of Clinical Oncology shows.
An analysis of 10 years of data from the UK Standardization of Breast Radiotherapy (START) trials A and B shows women with early-stage breast cancer may be able to have radiation therapy for a shorter amount of time, yet get the same treatment benefit.
An analysis of 15 years of data from the European Organization for Research and Treatment of Cancer study 10853 shows women with ductal carcinoma in situ (DCIS), the earliest stage of breast cancer, may reduce their risk of the cancer coming back by as much as 50 percent when treated with radiation therapy after lumpectomy.
NEW YORK (Reuters Health) - Poor young women are more likely to delay going to the doctor when they find a breast lump than women in better financial straits, a new study suggests.
Researchers surveyed young breast cancer patients about how they first discovered their cancer, how long they waited to see a doctor and how long after diagnosis they started treatment.
Women with lymphedema — swelling in the arm caused by the surgical removal of lymph nodes or by damage to the lymph nodes from radiation therapy for breast cancer — may perform upper-body strength training exercises with light and heavy weights, without worsening swelling or other lymphedema symptoms, Australian researchers say.
Young African-American women with breast cancer report more symptoms of depression than their healthy peers, even when they have good social support systems and an ability to adapt to new environments or situations, a study published in the Journal of Cancer Survivorship shows.
Women with HER2-positive metastatic breast cancer who experience growth or worsening of the disease after treatment with other anti-HER2 therapies can expect a significant progression-free survival benefit from the recently FDA approved antibody-drug conjugate T-DM1 (Kadcyla), first results from the phase III TH3RESA trial show. The findings were presented at the 2013 European Cancer Congress (ECC) in Amsterdam on September 28.
(Reuters) - Quest Diagnostics Inc on Tuesday became the largest U.S. company to start offering gene-based tests for inherited forms of breast cancer since the U.S. Supreme Court ended Myriad Genetics Inc's monopoly on the tests for specific gene mutations.
A study published in Psycho-Oncology suggests that the way a couple communicates about cancer-related concerns plays a role in worsening or improving symptoms of depression related to problems with sex and physical intimacy in women living with metastatic disease.